年轻高危前列腺癌:手术与放疗的癌症特异性死亡率比较
该回顾性研究基于SEER数据库2004至2012年数据,纳入2228例60岁以下高危局限性前列腺癌男性,比较初始根治性前列腺切除术与放疗的生存结局。多因素分析显示手术与更优的前列腺癌特异性和总体死亡率相关,但需前瞻性随机试验确认长期结局。
要点
- 60岁以下高危局限性前列腺癌中,初始手术组前列腺癌特异性死亡率低于放疗组。
- 多因素分析手术 vs 放疗的癌症特异性死亡HR 0.37(95%CI 0.19-0.74,p=0.005)。
- 总体死亡HR 0.41(95%CI 0.24-0.70,p=0.001),需前瞻性试验验证。
核心结论
- 在60岁以下高危局限性前列腺癌男性中,初始手术 compared with 初始放疗与更优的前列腺癌特异性和总体死亡率相关。
研究设计与样本
- 回顾性分析SEER数据库2004至2012年60岁以下接受初始手术或放疗的高危(Gleason评分≥8)局限性(N0M0 TNM分期)前列腺癌男性记录。
- 共纳入2228例,其中1459例(65.5%)接受初始手术,中位随访43个月;769例(34.5%)接受初始外照射放疗伴或不伴近距离放疗,中位随访44个月。
主要发现
- 多因素分析控制年龄、活检Gleason评分、T分期和前列腺特异性抗原后,初始手术 compared with 初始放疗与改善的前列腺癌特异性死亡率相关(HR 0.37,95%CI 0.19-0.74,p=0.005)。
- 初始手术 compared with 初始放疗与改善的总体死亡率相关(HR 0.41,95%CI 0.24-0.70,p=0.001)。
临床怎么用
- 对于60岁以下高危局限性前列腺癌男性,初始根治性前列腺切除术可能是改善生存的优选策略,但需个体化决策并等待前瞻性随机试验确认。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- 需未来前瞻性随机试验确认长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The optimal primary treatment of localized high grade prostate cancer in younger men remains controversial. The objective of this project was to compare the impact of initial radical prostatectomy vs radiation therapy on survival outcomes in young men less than 60 years old with high grade prostate cancer. MATERIALS AND METHODS: We retrospectively analyzed the records of men younger than 60 years in the SEER (Surveillance, Epidemiology and End Results) database who underwent initial surgery or radiation therapy of high grade (Gleason score 8 or greater) localized (N0M0 TNM stage) prostate cancer from 2004 to 2012. Univariate and multivariate Cox proportional hazards regression models were used to examine prostate cancer specific and overall mortality. RESULTS: A total of 2,228 men were identified, of whom 1,459 (65.5%) underwent initial surgery and had a median followup of 43 months and 769 (34.5%) underwent initial external beam radiation therapy with or without brachytherapy and had a median followup of 44 months. On multivariate analysis initial treatment with surgery was associated with improved prostate cancer specific and overall mortality compared with initial radiation treatment (HR 0.37, 95% CI 0.19-0.74, p = 0.005 vs HR 0.41, 95% CI 0.24-0.70, p = 0.001) when controlling for age, biopsy Gleason score, T stage and prostate specific antigen. CONCLUSIONS: Our data showed significant survival differences in young men treated initially with surgery vs external beam radiation therapy of high grade prostate cancer. Future prospective randomized trials are needed to confirm the long-term outcomes of these treatment approaches.
引用
- Huang H, Muscatelli S, Naslund M, et al. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years. J Urol. 2019. PMID: 30059685. doi:10.1016/j.juro.2018.07.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。